Graft-versus-host disease cost-effectiveness of therapy

	Graft-versus-host disease
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Graft-versus-host disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Graft-versus-host disease cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Graft-versus-host disease cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Graft-versus-host disease cost-effectiveness of therapy
CDC on Graft-versus-host disease cost-effectiveness of therapy
Graft-versus-host disease cost-effectiveness of therapy in the news
Blogs on Graft-versus-host disease cost-effectiveness of therapy
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Graft-versus-host disease cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Corticosteroids are the most cost-effective therapy for GvHD. Prednisone and methylprednisolone are available at very low cost. Second-line therapies and cell-based therapies are significantly more expensive. If corticosteroids can be used, these should be given first.